Dynavax's hep B vaccine meets main goals in late-stage study

(Reuters) - Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro